Kleopas A. Kleopa

6 Iroon Avenue
Nicosia, 2371, Cyprus

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

Clinicopathological and serological spectrum of idiopathic inflammatory myopathies: Experience from a neuromuscular referral center in Cyprus.

Clinicopathological and serological spectrum of idiopathic inflammatory myopathies: Experience from a neuromuscular referral center in Cyprus.

Journal: Journal of neuromuscular diseases

Published: August 18, 2026

Rituximab treatment in AChR-positive generalized myasthenia gravis within two years of diagnosis.

Rituximab treatment in AChR-positive generalized myasthenia gravis within two years of diagnosis.

Journal: Clinical neurology and neurosurgery

Published: May 26, 2026

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Journal: Brain : a journal of neurology

Published: February 11, 2026

A functional framework in patient fibroblasts informs ATP7A variant pathogenicity and identifies p.Q990P as a novel cause of distal motor neuropathy.

A functional framework in patient fibroblasts informs ATP7A variant pathogenicity and identifies p.Q990P as a novel cause of distal motor neuropathy.

Journal: Human molecular genetics

Published: December 23, 2025

A dose-escalation and safety gene therapy study in a model of CMT4C neuropathy.

A dose-escalation and safety gene therapy study in a model of CMT4C neuropathy.

Journal: Gene therapy

Published: December 11, 2025

Real-world use of efgartigimod in acetylcholine receptor antibody-positive generalized myasthenia gravis: experience from two centers in Greece and Cyprus.

Real-world use of efgartigimod in acetylcholine receptor antibody-positive generalized myasthenia gravis: experience from two centers in Greece and Cyprus.

Journal: Frontiers in neurology

Published: November 27, 2025

Progress and challenges in intrathecal gene therapy for neurological disorders.

Progress and challenges in intrathecal gene therapy for neurological disorders.

Journal: EBioMedicine

Published: November 05, 2025

Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1A.

Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1A.

Journal: Molecular therapy. Nucleic acids

Published: September 29, 2025

Subunit-Specific Immunodominance in Clinically Distinct Populations With AChR+ Myasthenia Gravis: A Multiparametric Cross-Sectional Analysis.

Subunit-Specific Immunodominance in Clinically Distinct Populations With AChR+ Myasthenia Gravis: A Multiparametric Cross-Sectional Analysis.

Journal: Neurology

Published: September 29, 2025

ChatGPT in the diagnosis and management of complex polyneuropathies: comparative analysis with neurologists using real-world cases.

ChatGPT in the diagnosis and management of complex polyneuropathies: comparative analysis with neurologists using real-world cases.

Journal: NPJ digital medicine

Published: June 23, 2025

Systemic lipid and glucose modulation differentially affects cognitive function and neuroinflammation in a mouse model of Alzheimer's disease.

Systemic lipid and glucose modulation differentially affects cognitive function and neuroinflammation in a mouse model of Alzheimer's disease.

Journal: Frontiers in neuroscience

Published: May 28, 2025

Facing the challenge of effective dosing, safety, and timing of intrathecal gene therapy for neurological disorders.

Facing the challenge of effective dosing, safety, and timing of intrathecal gene therapy for neurological disorders.

Journal: EBioMedicine

Published: April 16, 2025

Showing 1-12 of 95

Last Updated: 09/26/2026